Karanjin interferes with ABCB1, ABCC1, and ABCG2

Karanjin interferes with ABCB1, ABCC1, and ABCG2

PURPOSE: The prominent ATP-binding cassette (ABC) transporters ABCB1, ABCC1, and ABCG2 are involved in substance transport across physiological barriers and therefore in drug absorption, distribution, and elimination. They also mediate multi-drug resistance in cancer cells. Different flavonoids are...

Full description

Bibliographic Details
Main Authors:	Martin Michaelis, Florian Rothweiler, Thomas Nerreter, Mohsen Sharifi, Taravat Ghafourian, Jindrich Cinatl
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-03-01
Series:	Journal of Pharmacy & Pharmaceutical Sciences
Online Access:	https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/20635

Similar Items

Differential Effects of the Oncogenic BRAF Inhibitor PLX4032 (Vemurafenib) and its Progenitor PLX4720 on ABCB1 Function
by: Martin Michaelis, et al.
Published: (2014-04-01)

Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study
by: Ziba Sabet, et al.
Published: (2022-11-01)

CORRELATION BETWEEN CHEMOTHERAPY RESPONSE AND EXPRESSION PROFILES OF TRANSMEMBRANE PROTEINS: P-GLYCOPROTEIN (ABCB1), MRP2 (ABCC2), BCRP (ABCG2) IN PATIENTS WITH INVASIVE BREAST CANCER
by: К. Yu. Khristenko, et al.
Published: (2016-10-01)

Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2
by: Mark C. de Gooijer, et al.
Published: (2018-07-01)

Karanjin: a potential furanoflavonoid for neuroprotection
by: Gnanaraj, Charles, et al.
Published: (2024)

Differential Action of Silver Nanoparticles on ABCB1 (MDR1) and ABCC1 (MRP1) Activity in Mammalian Cell Lines
by: Damian Krzyzanowski, et al.
Published: (2021-06-01)

Nrf2-dependent and-independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress
by: Adachi, T., et al.
Published: (2007)

Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model
by: Thomas Wanek, et al.
Published: (2020-11-01)

Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat.
by: Silvia Gazzin, et al.
Published: (2011-01-01)

Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
by: Yongchao Zhang, et al.
Published: (2020-11-01)

Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs
by: Chung-Pu Wu, et al.
Published: (2020-01-01)

Hedgehog Pathway Inhibitor HhAntag691 Is a Potent Inhibitor of ABCG2/BCRP and ABCB1/Pgp
by: Yimao Zhang, et al.
Published: (2009-01-01)

ABCB1 and ABCC1 Function during TGF-β-Induced Epithelial-Mesenchymal Transition: Relationship between Multidrug Resistance and Tumor Progression
by: Kelli Monteiro da Costa, et al.
Published: (2023-03-01)

Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)
by: Juan Pablo Rigalli, et al.
Published: (2024-04-01)

Exploring pharmacokinetics of talazoparib in ABCB1/ABCG2-deficient mice using a novel UHPLC-MS/MS method
by: Zahra Talebi, et al.
Published: (2023-11-01)

Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat
by: Chung-Pu Wu, et al.
Published: (2021-03-01)

ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines
by: Chung-Pu Wu, et al.
Published: (2023-03-01)

Association of ABCB1, ABCC4 and SLCO1B1 polymorphisms with high dose-MTX blood concentration and adverse events in childhood acute lymphoblastic leukemia
by: TIAN Xiao-yi, LIU Ying, YAO Yao, GU Xiu-li, LI Ai-hua, ZHENG Hu-yong, SONG Wen-qi
Published: (2022-05-01)

Aurora kinases as targets in drug-resistant neuroblastoma cells.
by: Martin Michaelis, et al.
Published: (2014-01-01)

Impact of <i>ABCG2</i> and <i>ABCB1</i> Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis
by: Chiara Dalle Fratte, et al.
Published: (2023-02-01)

ABCB1 and ABCG2 Control Brain Accumulation and Intestinal Disposition of the Novel ROS1/TRK/ALK Inhibitor Repotrectinib, While OATP1A/1B, ABCG2, and CYP3A Limit Its Oral Availability
by: Wenlong Li, et al.
Published: (2021-10-01)

Isolation of Karanjin from Pongamia Pinnata and Its Identification by Difference Analytical Techniques
by: Sushil Kumar Dhanmane, et al.
Published: (2018-07-01)

Characteristics of ABCC4 and ABCG2 High Expression Subpopulations in CRC—A New Opportunity to Predict Therapy Response
by: Jakub Kryczka, et al.
Published: (2023-11-01)

Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines
by: Floren G. Low, et al.
Published: (2020-10-01)

Anti-tumor potential and mode of action of karanjin against breast cancer; an in-silico approach
by: Prarambh S.R. Dwivedi, et al.
Published: (2023-06-01)

Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells
by: Chung-Pu Wu, et al.
Published: (2023-09-01)

Long-term cultivation using ineffective MDM2 inhibitor concentrations alters the drug sensitivity profiles of PL21 leukaemia cells
by: Martin Michaelis, et al.
Published: (2020-01-01)

Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancerResearch in context
by: G.D. Marijn Veerman, et al.
Published: (2023-05-01)

Role of Two Efflux Proteins, ABCB1 and ABCG2 in Blood-Brain Barrier Transport of Bromocriptine in a Murine Model of MPTP-Induced Dopaminergic Degeneration
by: Sarah Vautier, et al.
Published: (2009-08-01)

NCX-4040, a Unique Nitric Oxide Donor, Induces Reversal of Drug-Resistance in Both ABCB1- and ABCG2-Expressing Multidrug Human Cancer Cells
by: Birandra K. Sinha, et al.
Published: (2021-04-01)

Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme
by: Dimitrios Vagiannis, et al.
Published: (2020-03-01)

Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia
by: Anna Marta Madejczyk, et al.
Published: (2022-09-01)

YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance Setting
by: Martin Michaelis, et al.
Published: (2020-04-01)

Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
by: Martin Michaelis, et al.
Published: (2020-03-01)

Increased HRD score in cisplatin resistant penile cancer cells
by: Ria Winkelmann, et al.
Published: (2022-12-01)

<i>ABCC1</i>, <i>ABCG2</i> and <i>FOXP3</i>: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis
by: Cristina Membrive-Jiménez, et al.
Published: (2023-09-01)

Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice
by: Kazuyoshi Furukawa, et al.
Published: (2024-03-01)

The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation
by: Tingting Wu, et al.
Published: (2023-07-01)

Pharmacogenetics of CYP450A, ABCB1, ABCC2, SLCO1B3 gene polymorphisms and plasma alpha-1-acid glycoprotein level on nonhaematological adverse events of docetaxel in Malaysian breast cancer patients
by: Jabir, Rafid Salim
Published: (2015)

Snapshots of ABCG1 and ABCG5/G8: A Sterol’s Journey to Cross the Cellular Membranes
by: Fatemeh Rezaei, et al.
Published: (2022-12-01)